Physician profile
Michael A Greene
NPI 1992867683
$1,436.76
in general payments reported to CMS, 2019-2025
12 companies · $428 in 2025
The $428 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.41 · 2020: $29.09 · 2021: $107 · 2022: $183 · 2023: $88.03 · 2024: $563 · 2025: $428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,079.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,078.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $561.17 | 2020-2025 | Apretude, Dovato, Cabenuva |
| Gilead Sciences, INC. | $487.71 | 2021-2025 | Biktarvy |
| Merck Sharp & Dohme LLC | $122.42 | 2021-2025 | Pifeltro, Delstrigo, Dificid |
| Inspire Medical Systems, INC. | $45.97 | 2025 | Inspire |
| Novo Nordisk INC | $42.71 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $42.11 | 2019-2025 | Breztri, Airsupra |
| Pfizer INC. | $33.13 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.86 | 2022-2024 | |
| Abbott Laboratories | $24.50 | 2025 | Freestyle Libre 3 |
| Janssen Biotech, INC. | $15.91 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $14.80 | 2024 | |
| Organon LLC | $14.47 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Greene listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.